Table 3.
Age group | Young (18–34 years) | Middle (35–64 years) | Old (65–84 years) |
---|---|---|---|
Tacrolimus
| |||
No. subjects | 266 | 1425 | 276 |
No. troughs | 4374 | 25194 | 4911 |
TAC trough (ng/mL) | 7.8(5.8–10.0) | 8.1(6.1–10.1) | 8.2(6.4–10.3) |
TAC daily dose (mg) | 7.0(4.0–10.0) | 6.0(4.0–8.0) | 5.0(3.0–8.0) |
Weight (kg) | 71.8(60.0–89.2) | 81.6(70.2–95.3) | 81.0(69.7–93.5) |
TAC dose-and weight-normalized trough | 77.1(48.5–127.0) | 111.4(68.9–180.0) | 129.8(84.5–201.2) |
| |||
Cyclosporine
| |||
No. subjects | 107 | 520 | 117 |
No. troughs | 1666 | 7687 | 1779 |
CSA trough (ng/mL) | 169.0(133.0–222.0) | 179.0(139.0–228.0) | 181.0(139.0–233.0) |
CSA daily dose (mg) | 350(300–450) | 350(250–400) | 250(200–350) |
Weight (kg) | 69.3(60.9–87.5) | 83.1(70.3–98.2) | 78.2(65.9–89.9) |
CSA dose and weight normalized trough | 34.6(24.1–51.4) | 46.7(33.0–65.2) | 54.6(39.9–74.1) |
TAC, tacrolimus; CSA, cyclosporine
Data are median and interquartile range (IQR)